EssilorLuxottica
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EssilorLuxottica - overview
Established
2018
Location
Charenton-le-Pont, -, France
Primary Industry
Healthcare Specialists
About
EssilorLuxottica is a global leader in the design, manufacture, and distribution of eyewear and vision care products, formed from the merger of Essilor and Luxottica to enhance vision health worldwide. EssilorLuxottica specializes in vision care and eyewear solutions, having been established in 2018 in Charenton-le-Pont, France. The company was created from the merger of Essilor and Luxottica, combining their strengths to innovate in the eyewear industry. Francesco Milleri, Jorge Gervasi, Paul du Saillant, and Toshiaki Shimakawa currently lead the company.
EssilorLuxottica specializes in the design, manufacture, and distribution of a wide range of vision care and eyewear products. The company’s core offerings include prescription lenses, optical equipment, and a variety of eyeglass frames and sunglasses from both proprietary brands and licensed labels. These products are aimed at addressing common vision challenges, such as myopia and presbyopia, while also emphasizing style and personal expression. EssilorLuxottica's client base spans various sectors including healthcare providers, optical retailers, and the general consumer market, with a strong presence in North America, Europe, and Asia Pacific.
The company also engages in innovative initiatives like myopia management and sustainability efforts, underscoring its commitment to technological advancement and environmental responsibility. EssilorLuxottica generated revenue of USD 23,446. 94 mn in 2021, with an EBITDA of USD 3,437. 69 mn in 2023.
The company generates its revenue through multiple channels, including direct sales to consumers, partnerships with retailers, and wholesale distribution to optical businesses. Transactions typically involve customers purchasing eyewear products and vision care solutions through various retail outlets or online platforms. The company employs a structured pricing model that varies based on product types and brand positioning, with flagship products often commanding premium pricing due to their design and technology. Overall, EssilorLuxottica's diverse revenue streams and product offerings position it as a significant player in the global eyewear market.
Primary Industry
Healthcare Specialists
Sub Industries
Optometrists & Opticians Products and Services
Website
www.essilorluxottica.com
Verticals
E-commerce, Manufacturing
Total Amount Raised
Subscriber access only
EssilorLuxottica - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 7,115,000,000 | 7,490,000,000 | 10,799,000,000 | 17,390,000,000 | 14,429,000,000 | 19,820,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | 5.3% | 44.2% | 61.0% | (17.0%) | 37.4% | - | - | - |
| EBITDA (USD) | 1,590,000,000 | 1,623,000,000 | 2,117,000,000 | 3,799,000,000 | 2,588,000,000 | 4,787,000,000 | - | - | - |
| Operating Income (USD) | 1,230,000,000 | 1,074,000,000 | 1,358,000,000 | 1,678,000,000 | 452,000,000 | 2,326,000,000 | - | - | - |
| Operating Margin | 17.3% | 14.3% | 12.6% | 9.6% | 3.1% | 11.7% | - | - | - |
| % EBITDA Margin | 22.3% | 21.7% | 19.6% | 21.8% | 17.9% | 24.2% | - | - | - |
| NET Income (USD) | 880,000,000 | 878,000,000 | 1,156,000,000 | 1,185,000,000 | 149,000,000 | 1,613,000,000 | - | - | - |
| % Net Margin | 12.4% | 11.7% | 10.7% | 6.8% | 1.0% | 8.1% | - | - | - |
EssilorLuxottica - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Optegra UK Limited | - | ||||||||
| Trade Sale | Completed | Optical Investment Group S.A. | - | ||||||||
| Trade Sale | Completed | Gentle Monster | - | ||||||||
| Trade Sale | Completed | Gentle Monster | - | ||||||||
| Trade Sale | Completed | GrandVision N.V. | - |
Displaying 1 - 5 of 5

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.